Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control (Q34386987)

1 August 2017

Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control (English)

1 reference

1 August 2017

T Yamanouchi

1

1 reference

1 August 2017

N Ogata

2

1 reference

1 August 2017

T Tagaya

3

1 reference

1 August 2017

T Kawasaki

4

1 reference

1 August 2017

N Sekino

5

1 reference

1 August 2017

H Funato

6

1 reference

1 August 2017

L Akaoka

7

1 reference

1 August 2017

H Miyashita

8

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 June 1996

1 reference

1 August 2017

1 reference

1 August 2017

347

1 reference

1 August 2017

1514-1518

1 reference

1 August 2017

9014

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990672-8

7 January 2021

Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990672-8

7 January 2021

Measurements of glucose control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990672-8

7 January 2021

Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990672-8

7 January 2021

Hemoglobin Alc--infatuation or the real thing?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990672-8

7 January 2021

Reduction and recovery of plasma 1,5-anhydro-D-glucitol level in diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990672-8

7 January 2021

Plasma 1,5-anhydro-D-glucitol as new clinical marker of glycemic control in NIDDM patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990672-8

7 January 2021

Reduced renal reabsorption of 1,5-anhydro-D-glucitol in diabetic rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990672-8

7 January 2021

Urinary excretion of 1,5-anhydro-D-glucitol accompanying glucose excretion in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990672-8

7 January 2021

Serum 1,5-anhydroglucitol (1,5 AG): new clinical marker for glycemic control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990672-8

7 January 2021

Comparison of 1,5-anhydroglucitol, HbA1c, and fructosamine for detection of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990672-8

7 January 2021

Calculating correlation coefficients with repeated observations: Part 1--Correlation within subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990672-8

7 January 2021

Marked depletion of plasma 1,5-anhydroglucitol, a major polyol, in streptozocin-induced diabetes in rats and the effect of insulin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990672-8

7 January 2021

Transport of 1,5-anhydro-D-glucitol across plasma membranes in rat hepatoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990672-8

7 January 2021

Transport of 1,5-anhydro-D-glucitol into human polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990672-8

7 January 2021

Estimation of plasma glucose fluctuation with a combination test of hemoglobin A1c and 1,5-anhydroglucitol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990672-8

7 January 2021

What is a significant change in the level of HbA1c?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990672-8

7 January 2021

Is serum anhydroglucitol an alternative to the oral glucose tolerance test for diabetes screening? The Mauritius Noncommunicable Diseases Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990672-8

7 January 2021

1,5-Anhydro-D-glucitol evaluates daily glycemic excursions in well-controlled NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990672-8

7 January 2021

Glycation products and the pathogenesis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990672-8

7 January 2021

10.1016/S0140-6736(96)90672-8

Identifiers

DOI

1 reference

1 August 2017

1 reference